Presentation Accelerated Platelet Inhibition by Switching from Atorvastatin to a Non-CYP3A4-Metabolized Statin Presenter: Y. Park April 24, 2012 REGISTER for free or LOG IN to view this content CAD Pharma Lipids Factoid Up Next Presentation DES vs. BMS in Primary Angioplasty: Pooled Patient-Level Meta-Analysis of Randomized Trials Presenter: Giuseppe De Luca April 24, 2012 More slides + Presentation When is TAVR Not Cost-Effective? Presenter: David J. Cohen April 25, 2012 Presentation What’s the Benchmark: Is there a Gold Standard for SFA Revascularization? Presenter: Lawrence A. Garcia April 25, 2012 We Recommend
Presentation DES vs. BMS in Primary Angioplasty: Pooled Patient-Level Meta-Analysis of Randomized Trials Presenter: Giuseppe De Luca April 24, 2012
Presentation What’s the Benchmark: Is there a Gold Standard for SFA Revascularization? Presenter: Lawrence A. Garcia April 25, 2012